Express Healthcare
Home  »  News  »  Metropolis Healthcare records Rs 303 Crs. revenue in Q2FY22

Metropolis Healthcare records Rs 303 Crs. revenue in Q2FY22

0 164
Read Article

Non-COVID revenue grows 38% YoY to Rs 260 Crs.

Metropolis Healthcare has announced its unaudited consolidated financial results for the second quarter (Q2FY22).

Q2FY22 financial highlights

  • 8% EBITDA margin (Before CSR & ESOP)
  • 60% revenue share of B2C in Focus Cities (Non-COVID)
  • 58.4 Crs reported PAT

Ameera Shah, Promoter and Managing Director, Metropolis Healthcare said, “We are pleased to share that we have continued the strong business momentum with recording robust revenue along with profitability during Q2FY22. This strong performance has been on the back of growth in sustainable non-COVID revenue, increased patient visits & tests and increased contribution from specialized tests. With economy now strongly recovering from the pandemic, we expect our non-COVID business to continue grow sustainably. Our recently acquired Hitech Diagnostics will further enable us to scale up our business, improve the B2C revenue contribution and increase our market penetration by catering to the value segment of the market.”

In INR Crs.Q2FY22Q2FY21
Revenue from Operations302.6288.4
EBIDTA before CSR & ESOP93.294.9
Reported Profit After Tax58.460.5
Reported PAT Margin (%)19.3%21.0%
Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
Are you looking for ICP-MS which can increase productivity and remove time trap from your analysis?
Know More
The Radiology Conclave : Embrace the new normal
Register Now